Advancing Chelator Technologies for Enhanced Radiopharmaceutical Development

  • Enhancing therapeutic performance by modifying drug properties for improved efficacy and safety
  • Selecting optimal chelators to maximize stability and target delivery
  • Optimizing pharmacokinetics and biodistribution to improve drug distribution and clearance for better clinical outcomes

New Company for 2026